Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4.
Peng, R., Li, Z., Xu, Y., He, S., Peng, Q., Wu, L.A., Wu, Y., Qi, J., Wang, P., Shi, Y., Gao, G.F.(2019) Proc Natl Acad Sci U S A 116: 18928-18936
- PubMed: 31467167 
- DOI: 10.1073/pnas.1909400116
- Primary Citation of Related Structures:  
6KL9, 6KLB - PubMed Abstract: 
Prokaryotes possess CRISPR-Cas systems to exclude parasitic predators, such as phages and mobile genetic elements (MGEs). These predators, in turn, encode anti-CRISPR (Acr) proteins to evade the CRISPR-Cas immunity. Recently, AcrVA4, an Acr protein inhibiting the CRISPR-Cas12a system, was shown to diminish Lachnospiraceae bacterium Cas12a (LbCas12a)-mediated genome editing in human cells, but the underlying mechanisms remain elusive ...